Technical Analysis for DEST - Destiny Pharma Plc

Grade Last Price % Change Price Change
C 167.5 -2.33% -4.00
DEST closed down 2.33 percent on Friday, April 16, 2021, on 51 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Flat
Historical DEST trend table...

Date Alert Name Type % Chg
Multiple of Ten Bearish Other 0.00%
Narrow Range Bar Range Contraction -2.33%
NR7 Range Contraction -2.33%
Multiple of Ten Bullish Other -2.33%
Bearish Engulfing Bearish 1.52%
Multiple of Ten Bearish Other 1.52%
Wide Bands Range Expansion 1.52%
Multiple of Ten Bullish Other -3.18%
Wide Bands Range Expansion -3.18%
Up 3 Days in a Row Strength -3.18%
Older End-of-Day Signals for DEST ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Destiny Pharma Plc Description

Destiny Pharma PLC is a United Kingdom-based clinical stage biotechnology company. The Company is focused on the development of medicines for the treatment of infectious disease. It is developing drugs for the prevention and treatment of infections caused by Antibiotic-Resistant (AR) bacteria. The exeporfinium chloride (XF) Drug series is the Company’s anti-microbial drug platform and comprises the related XF and drugs described by Destiny Pharma (DPD) drug candidate. Its pipeline for the XF Drug products includes XF-73 Nasal, XF-73 Throat, XF-70 Dermal and XF-70 Lung. XF-73 is a synthetic dicationic porphyrin derivative with antibacterial activity. XF-73 is in the clinical development stage for the prevention of post-surgical staphylococcal infections. XF-73 has completed four Phase I /II A studies in Europe.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Derivative Biotechnology Medicine Clinic Pipe Disease Xf Drugs Prevention Infection Antibiotic Infectious Infectious Disease Medication Bacteria Infections Stage Biotechnology G Series

Is DEST a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 250.0
52 Week Low 29.1
Average Volume 74,822
200-Day Moving Average 84.01
50-Day Moving Average 136.37
20-Day Moving Average 163.98
10-Day Moving Average 168.20
Average True Range 13.09
ADX 46.08
+DI 36.85
-DI 14.47
Chandelier Exit (Long, 3 ATRs ) 210.73
Chandelier Exit (Short, 3 ATRs ) 169.57
Upper Bollinger Band 185.77
Lower Bollinger Band 142.18
Percent B (%b) 0.58
BandWidth 26.58
MACD Line 10.32
MACD Signal Line 11.74
MACD Histogram -1.4182
Fundamentals Value
Market Cap 100.19 Million
Num Shares 59.8 Million
EPS -11.50
Price-to-Earnings (P/E) Ratio -14.57
Price-to-Sales 0.00
Price-to-Book 4.52
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 177.89
Resistance 3 (R3) 178.04 174.72 176.16
Resistance 2 (R2) 174.72 172.07 174.64 175.58
Resistance 1 (R1) 171.11 170.44 169.45 170.96 175.00
Pivot Point 167.79 167.79 166.96 167.72 167.79
Support 1 (S1) 164.18 165.15 162.52 164.04 160.00
Support 2 (S2) 160.86 163.51 160.79 159.42
Support 3 (S3) 157.26 160.86 158.84
Support 4 (S4) 157.11